Healthy potentially undervalued

Results

717

Companies which are potentially undervalued and in an acceptable financial position.

717 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
BLBD
US$60.50-3.2%4.0%US$1.9bUS$89.136.8-8.1%n/aCapital Goods
VLY
US$13.95-1.2%33.5%US$7.8bUS$16.751.014.6%3.2%Banks
ILPT
US$8.32-0.2%37.7%US$562.7mUS$11.171.220.7%4.8%Real Estate
PLOW
US$42.162.6%24.0%US$961.6mUS$54.0018.917.2%2.8%Capital Goods
LKQ
US$25.37-2.3%-21.3%US$6.5bUS$32.5013.816.5%4.7%Retail
SGRY
US$13.93-0.07%-38.7%US$1.8bUS$18.730.5125.8%n/aHealthcare
EXE
US$98.002.0%0.8%US$22.4bUS$125.528.2-0.5%3.3%Energy
FLOC
US$21.57-5.0%33.5%US$1.9bUS$31.0019.131.5%1.7%Energy
MYRG
US$309.39-2.7%61.5%US$4.9bUS$412.0029.117.6%n/aCapital Goods
INR
US$15.082.8%1.9%US$931.7mUS$22.635.558.2%n/aEnergy
AR
US$38.522.3%19.9%US$11.8bUS$49.4010.95.5%n/aEnergy
ACIW
US$54.235.1%10.2%US$5.4bUS$67.3324.316.1%n/aSoftware
XP
US$17.6910.6%-4.8%US$9.0bUS$22.578.711.3%1.1%Diversified Financials
LHX
US$261.98-3.1%-5.4%US$49.0bUS$339.5026.213.9%1.9%Capital Goods
TRLV
US$11.037.6%21.6%US$2.2bUS$18.181.9124.9%n/aPharmaceuticals & Biotech
BZ
US$18.0014.1%-22.1%US$8.4bUS$21.6711.7-3.0%0.9%Commercial Services
BYD
US$79.62-1.6%-8.3%US$5.9bUS$95.943.2-62.3%1.0%Consumer Services
SARO
US$25.08-0.6%-7.0%US$8.3bUS$35.8125.617.3%n/aCapital Goods
GFF
US$99.20-0.9%27.7%US$4.6bUS$125.5720.514.7%0.9%Capital Goods
LKNC.Y
US$35.25-3.0%-3.1%US$11.9bUS$48.0720.223.2%n/aConsumer Services
BWMX
US$15.920%19.5%US$637.7mUS$29.478.525.4%7.9%Retail
CRMD
US$8.39-1.5%-40.7%US$667.2mUS$15.403.5-3.2%n/aPharmaceuticals & Biotech
GTES
US$26.381.9%0.9%US$6.8bUS$33.4518.33.5%n/aCapital Goods
UTHR
US$527.911.3%71.8%US$22.2bUS$664.3317.315.6%n/aPharmaceuticals & Biotech
Page 1 of 20